Download PDF
Hamostaseologie 2022; 42(01): 007-008
DOI: 10.1055/a-1694-4829
Editorial

GTH 2022: Sustainable Collaboration

Jan Beyer-Westendorf
1   Thrombosis Research Unit, Division of Hematology, Department of Medicine I, University Hospital “Carl Gustav Carus” Dresden, Dresden, Germany
,
Ute Scholz
2   Center of Hemostasis, MVZ Labor Dr. Reising-Ackermann und Kollegen, Leipzig, Germany
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Dear colleagues and friends of the German Society of Thrombosis and Hemostasis Research (TH),



Publication History

Article published online:
23 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Ageno W. Treatment of Atypical Clots. Hamostaseologie 2022; 42: 10–18
    PubMed
  • 2 Voigtlaender M, Langer F. Management of Vascular Thrombosis in Patients with Thrombocytopenia. Hamostaseologie 2022; 42: 19–28
    PubMed
  • 3 Etheredge HR, Fabian J. Communication in Healthcare: Global challenges in the 21st Century. Hamostaseologie 2022; 42: 29–35
    PubMed
  • 4 Wagner M, Uzun, G, Bakchoul T, Althaus K. Diagnosis of Platelet Function Disorders: A Challenge for Laboratories. Hamostaseologie 2022; 42: 36–45
    PubMed
  • 5 Male C. Anticoagulation in Pediatric Patients. Hamostaseologie 2022; 42: 46–53
    PubMed
  • 6 Middeldorp S, Naue C, Köhler C. Thrombophilia, Thrombosis, and Thromboprophylaxis in Pregnancy: For What and in Whom? Hamostaseologie 2022; 42: 54–64
    PubMed
  • 7 Mailer RK, Kuta P, Renné T. An Update on Safe Anticoagulation. Hamostaseologie 2022; 42: 65–72
    PubMed
  • 8 Espinola-Klein C. When and How to Combine Antiplatelet and Anticoagulant Drugs? Hamostaseologie 2022; 42: 73–79
    PubMed